Total results651
Search criteria
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.70High >= 0.60Medium >= 0.40Low >= 0.30| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| DSG1 | Q02413 | Desmoglein-1 (Cadherin family member 4) (Desmosomal glycoprotein 1) (DG1) (DGI) (Pemphigus foliaceus antigen) | Disease related genesHuman disease related genesPlasma proteins | 1 | HypotrichosisPalmoplantar keratoderma | Adhesion and uptake mediationFusion and delivery mediationImmune mediation | 0 | 0.47 | ||
| DUSTY | Q6XUX3 | Dual serine/threonine and tyrosine protein kinase (EC 2.7.12.1) (Dusty protein kinase) (Dusty PK) (RIP-homologous kinase) (Receptor-interacting serine/threonine-protein kinase 5) (Sugen kinase 496) (SgK496) | Disease related genesEnzymesHuman disease related genes | Hereditary spastic paraplegia | Fusion and delivery mediationReceptor-signaling mediation | 0 | 0.47 | |||
| ENPP1 | P22413 | Ectonucleotide pyrophosphatase/phosphodiesterase family member 1 (E-NPP 1) (Alkaline phosphodiesterase I) (EC 3.1.4.1) (Membrane component chromosome 6 surface marker 1) (Nucleotide diphosphatase) (Nucleotide pyrophosphatase) (NPPase) (EC 3.6.1.9) (Phosphodiesterase I/nucleotide pyrophosphatase 1) (Plasma-cell membrane glycoprotein PC-1) [Cleaved into: Ectonucleotide pyrophosphatase/phosphodiesterase family member 1, secreted form] | CD markersDisease related genesEnzymes | 1 | Diabetes mellitusObesityPseudoxanthoma elasticum | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 0 | 0.47 | ||
| GNAO | P09471 | Guanine nucleotide-binding protein G(o) subunit alpha (EC 3.6.5.-) | Disease related genesHuman disease related genesPredicted intracellular proteins | Epilepsy | Fusion and delivery mediationReceptor-signaling mediation | 0 | 0.47 | |||
| IDE | P14735 | Insulin-degrading enzyme (EC 3.4.24.56) (Abeta-degrading protease) (Insulin protease) (Insulinase) (Insulysin) | EnzymesFDA approved drug targetsPlasma proteins | Inherited retinal dystrophySkin and skin-structure infection | Clinical-translation mediationFusion and delivery mediationImmune mediation | 0 | 0.47 | |||
| ITA2 | P17301 | Integrin alpha-2 (CD49 antigen-like family member B) (Collagen receptor) (Platelet membrane glycoprotein Ia) (GPIa) (VLA-2 subunit alpha) (CD antigen CD49b) | Cancer-related genesCD markersHuman disease related genes | 1 | Colorectal cancerSolid tumour/cancer | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 0 | 0.47 | ||
| KCMA1 | Q12791 | Calcium-activated potassium channel subunit alpha-1 (BK channel) (BKCA alpha) (Calcium-activated potassium channel, subfamily M subunit alpha-1) (K(VCA)alpha) (KCa1.1) (Maxi K channel) (MaxiK) (Slo-alpha) (Slo1) (Slowpoke homolog) (Slo homolog) (hSlo) | Disease related genesFDA approved drug targetsHuman disease related genes | 7 | EpilepsyAsthmaFunctional bladder disorder | Clinical-translation mediationFusion and delivery mediationImmune mediation | 0 | 0.47 | ||
| GLUT4 | P14672 | Solute carrier family 2, facilitated glucose transporter member 4 (Glucose transporter type 4, insulin-responsive) (GLUT-4) | Disease related genesMetabolic proteinsPotential drug targets | 12 | Diabetes mellitusType 2 diabetes mellitus | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 5 | 0.40 | ||
| KPCA | P17252 | Protein kinase C alpha type (PKC-A) (PKC-alpha) (EC 2.7.11.13) | Cancer-related genesEnzymesFDA approved drug targets | Human immunodeficiency virus diseaseMuscular atrophyNephritic syndrome | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 5 | 0.40 | |||
| MRC1 | P22897 | Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206) | CD markersFDA approved drug targetsPlasma proteins | 1 | COVID-19Type 2 diabetes mellitus | Adhesion and uptake mediationClinical-translation mediationImmune mediation | 5 | 0.40 |